Showing 21 - 40 results of 52 for search '"overactive bladder"', query time: 0.06s Refine Results
  1. 21
  2. 22
  3. 23

    Association between cardiometabolic index and overactive bladder in adult American women: A cross-sectional study. by Junhua Li, Min He, Yu Zhou

    Published 2025-01-01
    “…<h4>Background</h4>Overactive bladder (OAB) is a common disorder, particularly in women, and its symptoms, including urgency, frequency, and nocturia, can significantly affect quality of life. …”
    Get full text
    Article
  4. 24

    Multi-center, prospective, non-interventional, observational study on the efficacy and safety of Mirabek® in adult patients with overactive bladder by Jee Soo Park, Won Sik Jang, Jongchan Kim, Moon-Hwa Park, Won Sik Ham

    Published 2025-01-01
    “…"Purpose: Mirabegron, the first-in-class beta-3 agonist, is the mainstay medication for overactive bladder (OAB). The aim of this study was to investigate the efficacy and safety of generic drugs of mirabegron (Mirabek®) in adults diagnosed with OAB through a multicenter, prospective, non-interventional observational study. …”
    Get full text
    Article
  5. 25

    Treatment Patterns for Patients on Overactive Bladder Therapy: A Retrospective Statistical Analysis Using Canadian Claims Data by Adrian Wagg, Demitri Diles, Todd Berner

    Published 2016-10-01
    “…**Background:** Overactive bladder (OAB) is a chronic condition which may be associated with a significant negative impact on quality of life. …”
    Get full text
    Article
  6. 26
  7. 27

    The Efficacy and Safety of Propiverine Hydrochloride in Patients with Overactive Bladder Symptoms Who Poorly Responded to Previous Anticholinergic Agents by Naoya Masumori, Shintaro Miyamoto, Taiji Tsukamoto, Seiji Furuya, Akihiko Iwasawa, Takashi Sato, Naoki Itoh, Akihiko Shibuya, Toshiro Oda

    Published 2011-01-01
    “…To prospectively examine the efficacy and safety of propiverine hydrochloride in patients with overactive bladder (OAB) symptoms who poorly responded to previous treatment with solifenacin, tolterodine or imidafenacin. …”
    Get full text
    Article
  8. 28

    Relationship between alcohol use and overactive bladder disease: a cross-sectional study of the NHANES 2005–2016 by Yixin Zhang, Weijun Qin

    Published 2025-01-01
    “…BackgroundOveractive bladder syndrome (OAB) is a prevalent urological condition which has a substantial impact on the life quality of affected individuals, resulting in restrictions in daily activities and work productivity. …”
    Get full text
    Article
  9. 29
  10. 30

    Plain Language Summary of Publication: What is the effect of the medicine vibegron in the treatment of overactive bladder in patients with and without bladder leakage? by David Staskin, Jeffrey Frankel, Steven G. Gregg, Janet Owens-Grillo

    Published 2025-01-01
    “…What is this summary about? People with overactive bladder need to use the bathroom many times a day to urinate (pee). …”
    Get full text
    Article
  11. 31
  12. 32

    Long‐term follow‐up of intradetrusor botulinum toxin utilisation: A comparison of patients with multiple sclerosis and idiopathic overactive bladder by William Chui, Joshua Kealey, Henry H. Yao, Garson Chan, Alvaro Bazo, Richard Parkinson, Helen E. O'Connell, Johan Gani

    Published 2025-01-01
    “…Dose, efficacy, duration of effect, International Consultation on Incontinence Questionnaire Overactive Bladder (ICIQ‐OAB) and International Consultation on Incontinence Questionnaire Urinary Incontinence (ICIQ‐UI) measures and complication rates were recorded. …”
    Get full text
    Article
  13. 33

    Examining Symptom Management and Quality of Life of Loop Diuretic-Induced Overactive Bladder Among Heart Failure Patients: Physician and Patient Perspectives by Xin Pan PharmD, MPH, Christopher S Wilcox MD, PhD, Bertram Pitt MD, Salim Shah MPhil, PhD, Anandi V Law B.Pharm., MS, PhD, FAPhA

    Published 2025-02-01
    “…This survey study examined the impact of loop diuretic-induced overactive bladder (LD-OAB) symptoms on quality of life (QOL) in HF patients; and management of OAB by HF patients and physicians. …”
    Get full text
    Article
  14. 34
  15. 35
  16. 36
  17. 37

    Comparative Evaluation of the Safety and Efficacy of Long-Term Use of Imidafenacin and Solifenacin in Patients with Overactive Bladder: A Prospective, Open, Randomized, Parallel-Group Trial (the LIST Study) by Masayoshi Zaitsu, Koji Mikami, Noriko Ishida, Takumi Takeuchi

    Published 2011-01-01
    “…Objectives. Overactive bladder (OAB) is a chronic disease, but comparative trials of anticholinergics, which are commonly used for treatment of OAB, have generally been performed for up to 12 weeks only. …”
    Get full text
    Article
  18. 38
  19. 39
  20. 40